VivoSeq
Other

Primary Teeth

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Primary Teeth is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

15/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed6 · 46%
Unknown status3 · 23%
Terminated2 · 15%
Recruiting1 · 8%
Active, not recruiting1 · 8%

Trial Activity

13 trials

Vital Pulp Treatment in Primary Teeth
Active, not recruiting·UUniversity of Maryland, Baltimore·Phase 4·NCT02298504·76 enrolled
Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth
Terminated··Phase 2·NCT03786302·102 enrolled
Indirect Pulp Treatment in Primary Teeth
Unknown status··N/A·NCT04763057·88 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)